Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel Free NOEMW Stock Alerts

Noema Pharma (NOEMW) Competitors

Noema Pharma logo
$0.14 0.00 (0.00%)
As of 09:33 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

NOEMW vs. AGD, AWP, THQ, ACP, and THW

Should you buy Noema Pharma stock or one of its competitors? Noema Pharma's main competitors and comparable companies include Abrdn Global Dynamic Dividend Fund (AGD), abrdn Global Premier Properties Fund (AWP), Abrdn Healthcare Opportunities Fund (THQ), Abrdn Income Credit Strategies Fund (ACP), and Abrdn World Healthcare Fund (THW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Noema Pharma compare to Abrdn Global Dynamic Dividend Fund?

Abrdn Global Dynamic Dividend Fund (NYSE:AGD) and Noema Pharma (NASDAQ:NOEMW) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

In the previous week, Abrdn Global Dynamic Dividend Fund had 1 more articles in the media than Noema Pharma. MarketBeat recorded 1 mentions for Abrdn Global Dynamic Dividend Fund and 0 mentions for Noema Pharma. Noema Pharma's average media sentiment score of 1.79 beat Abrdn Global Dynamic Dividend Fund's score of 0.84 indicating that Noema Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Abrdn Global Dynamic Dividend Fund Positive
Noema Pharma Very Positive

Company Net Margins Return on Equity Return on Assets
Abrdn Global Dynamic Dividend FundN/A N/A N/A
Noema Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn Global Dynamic Dividend Fund$75.72MN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

Summary

Abrdn Global Dynamic Dividend Fund beats Noema Pharma on 2 of the 3 factors compared between the two stocks.

How does Noema Pharma compare to abrdn Global Premier Properties Fund?

Noema Pharma (NASDAQ:NOEMW) and abrdn Global Premier Properties Fund (NYSE:AWP) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
abrdn Global Premier Properties Fund$60.73MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
abrdn Global Premier Properties Fund N/A N/A N/A

In the previous week, abrdn Global Premier Properties Fund had 1 more articles in the media than Noema Pharma. MarketBeat recorded 1 mentions for abrdn Global Premier Properties Fund and 0 mentions for Noema Pharma. Noema Pharma's average media sentiment score of 1.79 beat abrdn Global Premier Properties Fund's score of 0.00 indicating that Noema Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Noema Pharma Very Positive
abrdn Global Premier Properties Fund Neutral

Summary

abrdn Global Premier Properties Fund beats Noema Pharma on 2 of the 3 factors compared between the two stocks.

How does Noema Pharma compare to Abrdn Healthcare Opportunities Fund?

Noema Pharma (NASDAQ:NOEMW) and Abrdn Healthcare Opportunities Fund (NYSE:THQ) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
Abrdn Healthcare Opportunities Fund-$28.02MN/AN/AN/AN/A

In the previous week, Abrdn Healthcare Opportunities Fund had 1 more articles in the media than Noema Pharma. MarketBeat recorded 1 mentions for Abrdn Healthcare Opportunities Fund and 0 mentions for Noema Pharma. Noema Pharma's average media sentiment score of 1.79 beat Abrdn Healthcare Opportunities Fund's score of -1.45 indicating that Noema Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Noema Pharma Very Positive
Abrdn Healthcare Opportunities Fund Negative

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
Abrdn Healthcare Opportunities Fund N/A N/A N/A

Summary

Noema Pharma beats Abrdn Healthcare Opportunities Fund on 2 of the 3 factors compared between the two stocks.

How does Noema Pharma compare to Abrdn Income Credit Strategies Fund?

Noema Pharma (NASDAQ:NOEMW) and Abrdn Income Credit Strategies Fund (NYSE:ACP) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
Abrdn Income Credit Strategies Fund N/A N/A N/A

In the previous week, Noema Pharma's average media sentiment score of 1.79 beat Abrdn Income Credit Strategies Fund's score of 0.00 indicating that Noema Pharma is being referred to more favorably in the media.

Company Overall Sentiment
Noema Pharma Very Positive
Abrdn Income Credit Strategies Fund Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
Abrdn Income Credit Strategies Fund$85.32MN/AN/AN/AN/A

Summary

Noema Pharma and Abrdn Income Credit Strategies Fund tied by winning 1 of the 2 factors compared between the two stocks.

How does Noema Pharma compare to Abrdn World Healthcare Fund?

Abrdn World Healthcare Fund (NYSE:THW) and Noema Pharma (NASDAQ:NOEMW) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Abrdn World Healthcare FundN/A N/A N/A
Noema Pharma N/A N/A N/A

In the previous week, Abrdn World Healthcare Fund had 1 more articles in the media than Noema Pharma. MarketBeat recorded 1 mentions for Abrdn World Healthcare Fund and 0 mentions for Noema Pharma. Noema Pharma's average media sentiment score of 1.79 beat Abrdn World Healthcare Fund's score of 0.98 indicating that Noema Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Abrdn World Healthcare Fund Positive
Noema Pharma Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn World Healthcare Fund$86.53MN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

Summary

Abrdn World Healthcare Fund beats Noema Pharma on 2 of the 3 factors compared between the two stocks.

Get Noema Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NOEMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NOEMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NOEMW vs. The Competition

Export
MetricNoema PharmaCapital Markets IndustryFinance SectorNASDAQ Exchange
Market CapN/A$5.18B$13.32B$13.27B
Dividend YieldN/A7.55%6.03%15.88%
P/E RatioN/A29.3724.5126.15
Price / SalesN/A1,271.28510.2693.06
Price / CashN/A47.7747.4551.25
Price / BookN/A3.502.706.34
Net IncomeN/A$417.69M$1.32B$361.18M
7 Day Performance20.69%-0.52%-0.80%-1.17%
1 Month PerformanceN/A5.46%1.25%-3.40%
1 Year PerformanceN/A3.53%8.36%3.28%

Noema Pharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOEMW
Noema Pharma
N/A$0.14
flat		N/AN/A$0.00N/AN/AN/A
AGD
Abrdn Global Dynamic Dividend Fund
N/A$11.86
+0.2%		N/A-14.3%$0.00$75.72MN/AN/A
AWP
abrdn Global Premier Properties Fund
N/A$10.63
-0.6%		N/A-14.5%$0.00$60.73MN/AN/A
THQ
Abrdn Healthcare Opportunities Fund
N/A$18.82
-0.2%		N/A+0.8%$0.00-$28.02MN/A1,088
ACP
Abrdn Income Credit Strategies Fund
N/A$4.46
-1.0%		N/A-23.2%$0.00$85.32MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NOEMW) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners
Elon Warns "America Will Go Bankrupt". Trump's Plan Inside.
National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...
American Hartford Gold | Sponsoredtc pixel
The last few crashes started exactly like this
Every major market crash shared one thing in common: most investors felt confident right before it hit. Ove...
Parkview Capital Group | Sponsoredtc pixel
My next big call (under $1)
Crypto traders have a name for this month... Uptober. Since 2013, Bitcoin has closed October higher in 10 of 1...
Crypto 101 Media | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
This AI fund posted a 34 percent annualized payout last month
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel
The SEC Just Opened The Floodgates…
The SEC removed the 25 year old Pattern Day Trader rule in June 2026, cutting the minimum to open a trading ac...
StocksToTrade | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end of AI data centers coming?
Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...
Chaikin Analytics | Sponsoredtc pixel